AnGes, Inc.
Everything filed on one company: the documents, the statements, the register, the board, the buyback and the property table — each figure as filed, with the report it came from.
Filings
Financials
Ownership
Governance
Capital Returns
Assets
Latest values as text and table
AnGes, Inc.
AnGes, Inc. (アンジェス株式会社, 4563), Pharmaceutical. 2 cross-shareholdings, a board of 8 and 10 largest shareholders, as filed on EDINET for the year to December 2025. EDINET filing S100XTMQ, filed 2026-03-25. Source: company filings on EDINET (Financial Services Agency of Japan).
Financial summary
| Fiscal year end | Revenue (¥bn) | Profit (¥bn) | Total assets (¥bn) | EPS (¥) | DPS (¥) | Employees |
|---|---|---|---|---|---|---|
| 2021-12-31 | 0.1 | −13.7 | 45.5 | −92.86 | — | 131 |
| 2022-12-31 | 0.1 | −14.7 | 38.8 | −94.29 | — | 138 |
| 2023-12-31 | 0.2 | −7.4 | 28.9 | −39.29 | — | 145 |
| 2024-12-31 | 0.6 | −28.1 | 4.7 | −119.53 | — | 55 |
| 2025-12-31 | 0.9 | −5.1 | 5.4 | −14.44 | — | 56 |
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON
Cross-shareholdings
| Company held | Shares | Book value (¥bn) | % of shares outstanding |
|---|---|---|---|
| FunPep Company Limited | 200,000 | 0.0 | 0.5 |
% of shares outstanding: shares held ÷ (issuer's issued shares − treasury shares) × 100, both as filed, the denominator taken from the issuer's own annual securities report nearest the holding's fiscal year end
Source: company filings on EDINET (Financial Services Agency of Japan). · JSON · Markdown